Schizophrenia Clinical Trial
Official title:
Computerized Cognitive Skills Training in Severe Mental Illness
Verified date | July 2017 |
Source | Nathan Kline Institute for Psychiatric Research |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study is designed to evaluate the effectiveness of computerized cognitive skills training for improving memory and problem-solving skills in inpatients with schizophrenia.
Status | Completed |
Enrollment | 448 |
Est. completion date | December 2016 |
Est. primary completion date | December 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Age 18 and above; 2. In- and out-patients; 3. DSM-IV diagnosis of schizophrenia (all subtypes) or schizoaffective disorder with illness duration >5 years; 4. Auditory and visual acuity adequate to complete cognitive tests; 5. Stable dose of oral atypical antipsychotic for at least 4 weeks; 6. Total PANSS score > 60; 7. Good physical health determined by physical examination from medical chart review; 8. Capacity and willingness to give written informed consent. 9. MMSE > 24 Exclusion Criteria: 1. Inability to read or speak English; 2. Documented disease of the central nervous system; 3. History of intellectual impairment pre-dating onset of symptoms of psychosis (e.g. mental retardation); 4. Clinically significant or unstable cardiovascular, renal, hepatic, gastrointestinal, pulmonary or hematological conditions; 5. HIV +; 6. Patients diagnosed with substance dependence; 7. Currently participating in another experimental study. |
Country | Name | City | State |
---|---|---|---|
United States | Manhattan Psychiatric Center | New York | New York |
Lead Sponsor | Collaborator |
---|---|
Nathan Kline Institute for Psychiatric Research | Manhattan Psychiatric Center |
United States,
Lindenmayer JP, McGurk SR, Mueser KT, Khan A, Wance D, Hoffman L, Wolfe R, Xie H. A randomized controlled trial of cognitive remediation among inpatients with persistent mental illness. Psychiatr Serv. 2008 Mar;59(3):241-7. doi: 10.1176/appi.ps.59.3.241. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) | Comprehensive battery of neuro-cognitive tests | Week 0, and Week 12 (after completion of Cognitive Remediation) | |
Secondary | Facial Emotional Discrimination Task (FEDT) and Facial Emotional Identification Task (FEIT) | Test of facial emotion presentations on pictures to patients | Week 0, and Week 12 (after compeltion of Cognitive Remediation) | |
Secondary | Personal and Social Performance Scale (PSP) | Social function scale with four sub domains of social functioning | Week 0, and Week 12 after completion of Cognitive Remediation | |
Secondary | Positive and Negative Syndrome Scale (PANSS) | 30 item Gold standard for measurement of psychiatric symptoms | Week 0, Week 6 (Midpoint) and Week 12 after completion of Cognitive Remediation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |